Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a FIH, open-label, dose escalation, phase I clinical trial to assess the safety and immunogenicity of the candidate ChAdOx1 Zika vaccine in healthy volunteers administered intramuscularly.
Epistemonikos ID: bbc632a3baee1357bb6c51ad4dd86741ee92babc
First added on: Mar 23, 2020